TRMT112
Multifunctional methyltransferase subunit TRM112-like protein
Also known as: HSPC152, HSPC170, hTrm112, TR112_HUMAN, TRM112, TRMT11-2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UI30
- Gene
- TRMT112
- Ensembl
- ENSG00000173113
- Chromosome
- 11
- Canonical length
- 125 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Microtubules
OverviewNCBI Gene
Enables protein heterodimerization activity; protein methyltransferase activity; and tRNA methyltransferase activator activity. Involved in macromolecule methylation and positive regulation of macromolecule metabolic process. Located in nucleoplasm and perinuclear region of cytoplasm. Part of protein-containing complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
125 residues, UniProt reviewed canonical sequence.
>Q9UI30|TRMT112
1 MKLLTHNLLS SHVRGVGSRG FPLRLQATEV RICPVEFNPN FVARMIPKVE WSAFLEAADN
61 LRLIQVPKGP VEGYEENEEF LRTMHHLLLE VEVIEGTLQC PESGRMFPIS RGIPNMLLSE
121 EETESLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TRMT112 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 247 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 247 nTPM
- adrenal gland: 230 nTPM
- ovary: 189 nTPM
- kidney: 157 nTPM
- pituitary gland: 155 nTPM
- blood vessel: 153 nTPM
Single-cell type
- oocytes: 1,151 nCPM
- migrating cytotrophoblasts: 649 nCPM
- differentiating spermatogonia: 623 nCPM
- esophageal basal cells: 609 nCPM
- cytotrophoblasts: 584 nCPM
- esophageal suprabasal cells: 514 nCPM
Immune cell
- memory B-cell: 807 nTPM
- total PBMC: 804 nTPM
- basophil: 709 nTPM
- naive B-cell: 705 nTPM
- plasmacytoid DC: 619 nTPM
- naive CD4 T-cell: 525 nTPM
Brain region
- choroid plexus: 88 nTPM
- hypothalamus: 84 nTPM
- white matter: 83 nTPM
- midbrain: 78 nTPM
- pons: 75 nTPM
- medulla oblongata: 70 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.09
- gnomAD pLI
- 0.14
- gnomAD missense Z
- -0.93
- DepMap mean gene effect
- -1.78
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- maturation of LSU-rRNA
- maturation of SSU-rRNA
- peptidyl-glutamine methylation
- positive regulation of rRNA processing
- rRNA (guanine-N7)-methylation
- rRNA methylation
- transcription initiation-coupled chromatin remodeling
- tRNA methylation
Molecular functions
- protein heterodimerization activity
- protein methyltransferase activity
- tRNA methyltransferase activator activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Trm112-like
- Trm112p-like protein
- Multifunctional methyltransferase subunit Trm112
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TRMT112 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TRMT112 as an antibody target. Whether an autoantibody or antibody against TRMT112 could matter depends on whether native TRMT112 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TRMT112 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TRMT112 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...